Search results for "Didi"

showing 10 items of 182 documents

On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds

2019

The most enigmatic aspect of the rise of Candida auris as a human pathogen is that it emerged simultaneously on three continents, with each clade being genetically distinct. Although new pathogenic fungal species are described regularly, these are mostly species associated with single cases in individuals who are immunosuppressed.The most enigmatic aspect of the rise of Candida auris as a human pathogen is that it emerged simultaneously on three continents, with each clade being genetically distinct. Although new pathogenic fungal species are described regularly, these are mostly species associated with single cases in individuals who are immunosuppressed. In this study, we used phylogeneti…

AzolesAntifungal AgentsLetterZoologyClimate changeHuman pathogenClose relativesMicrobial Sensitivity TestsFungusBiologyCommunicable Diseases EmergingSwampMicrobiologyBirds03 medical and health sciencesDrug Resistance Multiple FungalVirologyAnimalsHumansCladePhylogeny030304 developmental biologyCandida0303 health sciencesgeographygeography.geographical_feature_categoryPhylogenetic tree030306 microbiologyfungusCandidiasisTemperaturebiology.organism_classificationQR1-502Fungal diseaseclimate changeCandida auris13. Climate actionmBio
researchProduct

Choosing the Right Antifungal Agent in ICU Patients

2019

Fungi are responsible for around 20% of microbiologically documented infections in intensive care units (ICU). In the last decade, the incidence of invasive fungal infections (IFI), including candidemia, has increased steadily because of increased numbers of both immunocompromised and ICU patients. To improve the outcomes of patients with IFI, intensivists need to be aware of the inherent challenges. This narrative review summarizes the features of routinely used treatments directed against IFI in non-neutropenic ICU patients, which include three classes of antifungals: polyenes, azoles, and echinocandins. ICU patients' pathophysiological changes are responsible for deep changes in the phar…

AzolesAntifungal AgentsReviewKidney Function TestsInvasive aspergillosiEchinocandins0302 clinical medicineLiver Function Tests[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesMedicineDrug InteractionsPharmacology (medical)030212 general & internal medicineComputingMilieux_MISCELLANEOUSmedia_common[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases0303 health sciencesIncidenceIncidence (epidemiology)CandidiasisGeneral MedicineSerum concentrationIntensive care patients3. Good healthIntensive Care UnitsPractice Guidelines as Topic[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyCandidiasiNarrative reviewDrug MonitoringInvasive fungi infectionAntifungalDrugmedicine.medical_specialtyIcu patientsmedicine.drug_classmedia_common.quotation_subjectPharmacokineticPolyenesImmunocompromised Host03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemIntensive careHumansPharmacokinetics[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologyIntensive care medicineIntensive care patient030306 microbiologybusiness.industry[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyInvasive aspergillosisLiver functionbusinessPractical guidelinesInvasive Fungal InfectionsAdvances in Therapy
researchProduct

Therapeutic tools for oral candidiasis : current and new antifungal drugs

2019

Background Candidiasis is one of the most common opportunistic oral infections that presents different acute and chronic clinical presentations with diverse diagnostic and therapeutic approaches. The present study carries out a bibliographic review on the therapeutic tools available against oral candidiasis and their usefulness in each clinical situation. Material and Methods Recent studies on treatment of oral candidiasis were retrieved from PubMed and Cochrane Library. Results Nystatin and miconazole are the most commonly used topical antifungal drugs. Both antifungal drugs are very effective but need a long time of use to eradicate the infection. The pharmacological presentations of mico…

AzolesNystatinmedicine.medical_specialtyAntifungal AgentsDatabases FactualMiconazolePyridinesItraconazoleAdministration TopicalAdministration OralReviewAnidulafunginEchinocandins03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCandidiasis OralCaspofunginAmphotericin BNitrilesmedicineHumansDrug InteractionsClotrimazoleFluconazoleGeneral DentistryVoriconazoleOral Medicine and Pathologybusiness.industryClotrimazole030206 dentistryTriazoles:CIENCIAS MÉDICAS [UNESCO]bacterial infections and mycosesDermatologyNystatinOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASAnidulafunginAdministration IntravenousSurgeryCaspofunginMiconazolebusinessFluconazolemedicine.drug
researchProduct

Sapieżyńska ochrona dóbr Potockich w starostwie owruckim w latach 80. i 90. XVII wieku Przyczynek do badań nad współpracą rodzin magnackich w czasach…

2019

The Sapiehas and the Potockis were amongst the most influential families of the Polish‑Lithuanian Commonwealth. The latter family owned numerous estates in Ukraine, which were directly under threat from marching Lithuanian soldiers. Kazimierz Jan Sapieha, Grand Hetman of Lithuania was in charge of the said estates. Due to cooperation of the two magnate families, he attempted to shield the Potockis’ estates and possessions from Lithuanian troops marching to or returning from the war with Turkey. To that aim he utilised legal proclamations called Universals. The Potockis returned the favour by entering into political collaboration. Hetman Kazimierz Jan Sapieha, having been absent from the Sie…

Bajorai didikai ir magnatai / Nobles and magnatesUkraina (Ukraine)Sapiegos (Sapiega family)Lietuva (Lithuania)Dvarai / ManorsLenkija (Lenkijos karalystė; Rzeczpospolita Polska; Kingdom of Poland; Poland)Kariuomenė / ArmyŽemėvalda. Žemėtvarka / Land managementTurkija (Turkey)Potockiai (Potockis family)Abiejų Tautų Respublika (ATR; Rzeczpospolita Obojga Narodów; Žečpospolita; Sandrauga; Polish-Lithuanian Commonwealth; Lenkija ir Lietuva; Lenkijos ir Lietuvos Valstybė; Lenkijos-Lietuvos unija)
researchProduct

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.

2014

Aim The efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, was evaluated in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and pioglitazone. Methods In this randomized, double-blind, phase 3 study, patients (N = 342) received canagliflozin 100 or 300 mg during a 26-week, placebo-controlled, core period and a 26-week, active-controlled extension in which placebo-treated patients were switched to sitagliptin 100 mg. Efficacy comparisons for canagliflozin versus placebo at week 26 are reported, with no comparisons versus sitagliptin at week 52 (sitagliptin used to maintain double-blind and control for safety). Safety data ar…

Blood GlucoseMaleendocrine system diseasesEndocrinology Diabetes and Metabolismphase 3 studyBlood PressureType 2 diabetesPharmacologyEndocrinologyGlucosidesWeight lossCanagliflozinCandidiasisSGLT2 inhibitorMiddle AgedDiuretics OsmoticLipidsMetforminMetforminTreatment OutcomePyrazinesDrug Therapy CombinationFemaletype 2 diabetesmedicine.symptomSGLT2 InhibitorGenital Diseases Malemedicine.drugmedicine.medical_specialtyUrologyThiophenesDouble-Blind MethodWeight LossInternal MedicinemedicineHumansHypoglycemic AgentsCanagliflozinthiazolidinedionesPioglitazonebusiness.industrySitagliptin Phosphatenutritional and metabolic diseasesType 2 Diabetes MellitusOriginal ArticlesTriazolesmedicine.diseaseBlood pressureDiabetes Mellitus Type 2businessPioglitazoneGenital Diseases FemaleDiabetes, obesitymetabolism
researchProduct

Ecotourism in Bolivia : an ethnographical study of ecotourism impacts in Madidi National Park

2016

Master thesis development management - University of Agder 2016 The concepts of ecotourism are widely defined but it is often used as a marketing instrument in order to promote tourism businesses related to nature. Ecotourism experience a fast growth in world tourism industry and many developing countries are trying to use ecotourism as a tool to achieve sustainable development. Ecotourism provides many beneficiaries to local environments, economies and socio-cultural lives. However, ecotourism may as well have harmful effects on those involved. Still, ecotourism conserves and protects local areas and its people. Madidi National Park in Bolivia has been estimated to be one of the world’s mo…

Boliviatourism impactspotentialsecotourismMadidi National Parksustainable developmentUT503VDP::Social science: 200::Social anthropology: 250indigenous communitieschallengesrainforest
researchProduct

Impaired immune response to Candida albicans in aged mice

2006

The prevalence of opportunistic fungal infections has increased dramatically among the aged population in recent years. This work investigated the effect of ageing on murine defences against Candida albicans. Aged C57BL/6 mice that were experimentally infected intravenously had a significantly impaired survival and a higher tissue fungal burden compared with young mice. In vitro production of tumour necrosis factor (TNF)-α by macrophages from aged mice in response to yeast cells and hyphae of C. albicans was significantly lower than production by macrophages from young mice. In vitro production of cytokines, such as TNF-α and gamma interferon (IFN-γ), by antigen-stimulated splenocytes from …

CD4-Positive T-LymphocytesMicrobiology (medical)AgingNecrosisBlotting WesternHyphaeMicrobiologyMicrobiologyInterferon-gammaMiceImmune systemAntigenCandida albicansmedicineAnimalsCandida albicansAntibodies FungalCells CulturedbiologyTumor Necrosis Factor-alphaVaccinationCandidiasisGeneral Medicinebiology.organism_classificationAcquired immune systemCorpus albicansMice Inbred C57BLImmunoglobulin GInjections IntravenousImmunologyMacrophages Peritonealbiology.proteinFemaleTumor necrosis factor alphaDisease SusceptibilityFungal Vaccinesmedicine.symptomAntibodySpleenJournal of Medical Microbiology
researchProduct

Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study

2011

Objectives: To provide a global, up-to-date picture of the prevalence, treatment, and outcomes of Candida bloodstream infections in intensive care unit patients and compare Candida with bacterial bloodstream infection. Design: A retrospective analysis of the Extended Prevalence of Infection in the ICU Study (EPIC II). Demographic, physiological, infection-related and therapeutic data were collected. Patients were grouped as having Candida, Gram-positive, Gram-negative, and combined Candida/bacterial bloodstream infection. Outcome data were assessed at intensive care unit and hospital discharge. Setting: EPIC II included 1265 intensive care units in 76 countries. Patients: Patients in partic…

Candida albicanMaleAntifungal AgentsIron metabolism Pathogenesis and modulation of inflammation [IGMD 7]Settore MED/41 - AnestesiologiaCritical Care and Intensive Care Medicinelaw.inventionEchinocandinschemistry.chemical_compound0302 clinical medicineRetrospective StudieCaspofunginlawCandida albicansPrevalenceAntifungal Agent030212 general & internal medicineCandida albicansFluconazoleMESH: SepsisFungemiaintensive careMedicine(all)MESH: AgedCross Infection0303 health scienceseducation.field_of_studyMESH: Middle AgedfungemiabiologyCandidiasisMiddle AgedIntensive care unitMESH: Candidiasisbacteremia; epidemiology; fungemia; intensive care; outcome assessment (health care); Aged; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Echinocandins; Female; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Male; Middle Aged; Prevalence; Retrospective Studies; Sepsis; Critical Care and Intensive Care Medicine3. Good healthIntensive Care Unitsbacteremia epidemiology fungemia intensive care outcome assessment (health care)CandidiasiMESH: FluconazoleepidemiologyFemaleHumanmedicine.drugmedicine.medical_specialtySepsiIntensive Care UnitPopulationLipopeptides03 medical and health sciencesSepsisIntensive caremedicineHumansEchinocandinbacteremiaIntensive care medicineeducationMESH: PrevalenceAgedRetrospective Studiesoutcome assessment (health care)MESH: Humans030306 microbiologybusiness.industryMESH: Candida albicansMESH: EchinocandinsMESH: Cross InfectionMESH: Retrospective Studies[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyMESH: Antifungal Agentsmedicine.diseasebiology.organism_classificationMESH: MalechemistryBacteremiaMESH: Intensive Care UnitsCaspofunginbusinessMESH: FemaleFluconazole
researchProduct

Aislamiento de Candida dubliniensis en un adolescente con estomatitis protésica

2005

Objetivos: Utilizar varios métodos que permiten la diferenciación entre Candida albicans y Candida dubliniensis en un intento de conocer si C. dubliniensis puede ser aislada de la cavidad oral de adolescentes con prótesis ortopédicas orales. Materiales y métodos: Se aislaron 12 cepas de género Candida procedentes de mucosa palatina y de soporte de prótesis de 12 pacientes adolescentes portadores de prótesis ortopédicas orales. Para la diferenciación entre C. albicans y C. dubliniensis se utilizaron varias pruebas fenotípicas (la asimilación de fuentes de carbono con el método comercial ID 32C, el crecimiento en agar glucosado de Sabouraud a 45 ºC, la producción abundante de clamidosporas en…

Candida dubliniensisestomatitis protésicaUNESCO::CIENCIAS MÉDICASCandidiasisOdontología:CIENCIAS MÉDICAS [UNESCO]Ciencias de la salud
researchProduct

Being candid about Candida airway colonization and clinical outcomes: What can we really learn from unadjusted associations?

2020

Candida sppmedicine.medical_specialtyCross InfectionLung Diseases FungalEpidemiologybusiness.industryHealth PolicyRespiratory SystemPublic Health Environmental and Occupational HealthCandidiasisColony Count MicrobialInfectious DiseasesmedicineHumansColonizationAirwayIntensive care medicinebusinessAsymptomatic InfectionsCandidaAmerican journal of infection control
researchProduct